Publication Name	World Journal of Experimental Medicine
Manuscript ID	3825
Country	Greece

Received	2013-05-26 07:42
Peer-Review Started	2013-05-26 19:09
To Make the First Decision	2013-06-24 10:26
Return for Revision	2013-07-01 13:41
Revised	2013-07-08 23:25
Second Decision	2013-08-16 19:50
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-08-17 00:36
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-08-26 13:47
Publish the Manuscript Online	2013-09-14 11:34

ISSN	2220-315x (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets
Manuscript Source	Invited Manuscript
All Author List	Maria Dalamaga
Funding Agency and Grant Number
Corresponding Author	Maria Dalamaga, MD, PhD, MS, MPH, Assistant Professor, Department of Clinical Biochemistry, Medical School, University of Athens, “Attikon” General University Hospital, 1 Rimini Street, Chaidari, 12462 Athens, Greece. madalamaga@med.uoa.gr
Key Words	Breast cancer; Obesity; Insulin resistance; Adipokines; Adiponectin; Resistin; Leptin; Nicotinamide phosphoribosyl-transferase; Visfatin
Core Tip	Recent evidence has shown that the constellation of obesity, insulin resistance and adipokines is associated with the risk and prognosis of postmenopausal breast cancer (BC). Direct evidence is growing rapidly supporting the stimulating and/or inhibiting role of adipokines in the process of development and progression of BC. Recent studies support a role of adipokines as novel risk factors and potential diagnostic and prognostic biomarkers in BC. This editorial aims at providing important insight into the potential pathophysiological mechanisms linking adipokines to the etiopathogenesis of BC in the context of a dysfunctional adipose tissue and insulin resistance in obesity. Understanding of these mechanisms may be important for the development of attractive preventive and therapeutic strategies against obesity-related breast malignancy.
Publish Date	2013-09-14 11:34
Citation	Dalamaga M. Obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets. World J Exp Med 2013; 3(3): 34-42
URL	http://www.wjgnet.com/2220-315X/full/v3/i3/34.htm
DOI	http://dx.doi.org/10.5493/wjem.v3.i3.34

Full Article (PDF)	WJEM-3-34.pdf
Manuscript File	3825-Review.docx
Answering Reviewers	3825-Answering reviewers.pdf
Biostatistics Review Certificate	editorial and biostatistics.docx
Copyright License Agreement	3825-Copyright assignment.doc
Institutional Review Board Approval Form or Document	editorial and ethics committee.docx
Non-Native Speakers of English Editing Certificate	editorial and language editing.docx
Peer-review Report	3825-Peer review(s).pdf
Scientific Editor Work List	3825-Scientific editor work list.doc